StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) shareholders

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Ownership

Who owns AXIM Biotechnologies's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Catalina Valencia
President and Director, 10% owner
Jan 30, 2024Buy+1,086,216––28,608,220
Catalina Valencia
10% owner
Aug 24, 2022Buy+3,861,004$0.03$115.83K23,661,004
Blake Schroeder
Director
Aug 22, 2022Conversion+854,012$0.03$25.62K854,012
John Walter Huemoeller Ii
Chief Executive Officer, Director
Mar 19, 2020Buy+6,000,000––6,000,000
Robert Malasek
CFO
Mar 21, 2018Award+50,000––50,000
Marijuana Inc Medical
10% owner
Dec 2, 2016Award+7,200,000––22,669,125
Marijuana Inc Medical
10% owner
Dec 2, 2016Award+7,200,000––22,143,650
Marijuana Inc Medical
10% owner
Nov 21, 2016Award+500,000––500,000
Lekhram Changoer
Director, 10% owner
Nov 21, 2016Award+240,000––2,265,000
Lekhram Changoer
Director, 10% owner
Nov 21, 2016Award+500,000––500,000
Lekhram Changoer
Director, 10% owner
Nov 21, 2016Award+2,000,000––2,265,000
Marijuana Inc Medical
10% owner
Nov 21, 2016Award+500,000––500,000
George Anastassov
CEO/Secretary, Director, 10% owner
Nov 21, 2016Award+500,000––500,000
George Anastassov
CEO/Secretary, Director, 10% owner
Nov 21, 2016Award+2,000,000––3,002,000
George Anastassov
CEO/Secretary, Director, 10% owner
Nov 21, 2016Award+250,000––3,002,000
George Anastassov
President, Director, 10% owner
Feb 5, 2016Award+125,000––15,365,650
Lekhram Changoer
Director, 10% owner
Dec 18, 2015Award+25,000––25,000
George Anastassov
President, Director, 10% owner
Nov 9, 2015Award+125,000––15,240,650
George Anastassov
President, Director, 10% owner
Jul 2, 2015Award+500,000––15,240,650
Lekhram Changoer
Director, 10% owner
Apr 23, 2015Award+1,000,000––1,500,000
George Anastassov
President, Director, 10% owner
Apr 23, 2015Award+1,000,000––1,500,000
George Anastassov
President, Director, 10% owner
Feb 23, 2015Award+2,000––14,945,650
Rosemary Samuels
PRESIDENT, CEO, CFO, Director, 10% owner
Mar 21, 2014Sale−1,000,000$400.00$400.00M0
Rosemary Samuels
PRESIDENT, CEO, CFO, Director, 10% owner
Mar 21, 2014Sale−20,000,000$8000.00$160.00B0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-44.4%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of AXIM Biotechnologies's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?